Symbiosis Pharmaceutical Services has extensive experience, skill and a proven track record in taking precious and complex drug products, ranging from small molecules to vaccines and ATMPs from manufacturing to QP release.
The aseptic fill finish manufacturing of drug products is challenging. Finding a suitable GMP aseptic fill finish manufacturer with the proven track record of delivering projects in short timelines can be difficult.
It can be especially challenging to find a partner with the right capabilities and experience to handle advanced therapeutics such as viral vectors or antibody drug conjugates.
Symbiosis has extensive experience in taking precious drug products through manufacturing, testing, label and packaging, storage, distribution and QP release. Our expert project management team offers a single point of contact throughout each project, ensuring that communication happens as clearly and as frequently as you need.
Symbiosis’ GMP compliant, aseptic fill finish manufacturing facility is fully licenced by the MHRA, so rest assured, you’re in safe hands.
Establishing a production and purification process for your drug substance is a significant achievement. However, you still need to get this into the format that can be administered to the patient in a reliable and safe manner.
Consideration must be given to the final composition (e.g. buffers and any other additives) as well as any special handling and storage requirements for your product. The container system must also be considered as some therapies, especially the advanced therapies, have limited compatibility with traditional glass vials.
Symbiosis has a range of validated options which can be used to successfully deliver your precious product to the patient quickly.
